Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiguo Wan

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Journal of Dermatological Science|May 24, 2017
Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathwayXiaoxia Zhu, Haiyan Chu, Shuai Jiang, et al.
Biomaterials Research|September 24, 2025
Mesenchymal Stem Cell-Derived Exosomes Inhibit Stim1-Orai1 Signaling and Calcium Overload-Induced Mitochondrial Damage of Follicular Helper T Cells in LupusYingyu Wang, Qingyong Xiang, Yueren Wu, et al.
Scientific Reports|February 28, 2025
Exosomes carrying adipose mesenchymal stem cells function alleviate scleroderma skin fibrosis by inhibiting the TGF-β1/Smad3 axisYu Xiao, Qingyong Xiang, Yingyu Wang, et al.
Rheumatology and Therapy|January 19, 2020
Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label StudyJing Zhang, Weiguo Wan, Liyan Miao, et al.
European Journal of Pharmacology|February 20, 2022
Pinocembrin mediates antiarrhythmic effects in rats with isoproterenol-induced cardiac remodelingXiaoli Chen, Weiguo Wan, Qian Ran, et al.
BMC Musculoskeletal Disorders|November 24, 2022
Spontaneous tendon rupture in a patient with systemic sclerosis: a case reportCong Lin, Jun Shen, Zhixing Jiang, et al.
Life Sciences|March 30, 2021
Pinocembrin alleviates lipopolysaccharide-induced myocardial injury and cardiac dysfunction in rats by inhibiting p38/JNK MAPK pathwayChuang Li, Weiguo Wan, Tianxin Ye, et al.
Lupus Science & Medicine|February 2, 2022
Low-dose belimumab for patients with systemic lupus erythematosus at low disease activity: protocol for a multicentre, randomised, double-blind, placebo-controlled clinical trialFangfang Sun, Wenyan Huang, Jie Chen, et al.
Lupus Science & Medicine|October 23, 2020
Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trialsFangfang Sun, Shikai Geng, Haiting Wang, et al.
Frontiers in Pharmacology|January 4, 2021
Pinocembrin Decreases Ventricular Fibrillation Susceptibility in a Rat Model of DepressionTianxin Ye, Cui Zhang, Gang Wu, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Journal of Dermatological Science|May 24, 2017
Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathwayXiaoxia Zhu, Haiyan Chu, Shuai Jiang, et al.
Biomaterials Research|September 24, 2025
Mesenchymal Stem Cell-Derived Exosomes Inhibit Stim1-Orai1 Signaling and Calcium Overload-Induced Mitochondrial Damage of Follicular Helper T Cells in LupusYingyu Wang, Qingyong Xiang, Yueren Wu, et al.
Scientific Reports|February 28, 2025
Exosomes carrying adipose mesenchymal stem cells function alleviate scleroderma skin fibrosis by inhibiting the TGF-β1/Smad3 axisYu Xiao, Qingyong Xiang, Yingyu Wang, et al.
Rheumatology and Therapy|January 19, 2020
Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label StudyJing Zhang, Weiguo Wan, Liyan Miao, et al.
European Journal of Pharmacology|February 20, 2022
Pinocembrin mediates antiarrhythmic effects in rats with isoproterenol-induced cardiac remodelingXiaoli Chen, Weiguo Wan, Qian Ran, et al.
BMC Musculoskeletal Disorders|November 24, 2022
Spontaneous tendon rupture in a patient with systemic sclerosis: a case reportCong Lin, Jun Shen, Zhixing Jiang, et al.
Life Sciences|March 30, 2021
Pinocembrin alleviates lipopolysaccharide-induced myocardial injury and cardiac dysfunction in rats by inhibiting p38/JNK MAPK pathwayChuang Li, Weiguo Wan, Tianxin Ye, et al.
Lupus Science & Medicine|February 2, 2022
Low-dose belimumab for patients with systemic lupus erythematosus at low disease activity: protocol for a multicentre, randomised, double-blind, placebo-controlled clinical trialFangfang Sun, Wenyan Huang, Jie Chen, et al.
Lupus Science & Medicine|October 23, 2020
Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trialsFangfang Sun, Shikai Geng, Haiting Wang, et al.
Frontiers in Pharmacology|January 4, 2021
Pinocembrin Decreases Ventricular Fibrillation Susceptibility in a Rat Model of DepressionTianxin Ye, Cui Zhang, Gang Wu, et al.
Pageof 9